New Drug Combination Activates Natural Killer Cells in Melanoma Model - Technology Networks

A new study finds that a unique combination drug strategy could activate natural killer cells to reinvigorate T cells to attack melanoma tumors.

Most skin cancer drugs that activate the immune system work by triggering immune cells, called T cells, to attack tumors, but when T cells are activated for too long, they can wear out and cease to f… [+5526 chars]

full article...